波色单双

Skip to Content on Nemours.org
You're location is
All Regions
波色单双

Nationally Recognized Pediatric Care

Our hospitals are ranked by U.S. News & World Report as among the best in the nation in multi-specialties.

Find Out Why!
Closeup of a person holding a phone using the Nemours app.

We Make Health Care Easy With the Nemours App

Access communications, appointment and symptom tracking and more.

Online Bill Pay

Paying a bill online is easy and secure.

Learn More

Send a Free E-Card

Brighten the day of your loved one staying at one of our hospitals.聽

Give It a Try
Young child posing with arms out like he is flying.

KidsHealth Library

Healthy living for聽parents, kids and聽teens.

Meet Our Team

Learn more about our physician researchers, clinicians and scientists.

Find a Researcher
# #

    Susan C. Adeniyi-Jones, MD

    Neonatologist
    Provider Profile

    波色单双, Philadelphia 833 Chestnut St. E. Suite 300 - Specialty Care Philadelphia, PA 19107

    Fellowship

    • Neonatology - Children's Hospital of Buffalo, 1987
    • Endocrinology - National Institute of Child Health, 1985

    Internship

    • The Walsgrave Hospital, 1977
    • Selly Oak Teaching Hospital, 1978

    Residency

    • Pediatrics - Queen Elizabeth II & St. Alban
    • Pediatrics - The Hospital for Sick Children, 1981
    • Pediatrics - The Children's Hospital, 1980

    Education

    • M.D. - Birmingham University Medical School, 1977

    Board Certifications

    • American Board of Pediatrics/Neonatal-Perinatal
    • American Board of Pediatrics/General Pediatrics

    • Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS); Journal of Perinatology; (2024).

    • Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study; Journal of Perinatology; (2024).

    • Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial; Journal of Perinatology; (2023).

    • Algorithms for treatment of Neonatal Opioid Withdrawal Syndrome (NOWS) based on Modified and Abbreviated Finnegan Symptom Score; Unknown Source; (2023).

    • Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome.; Pediatric research; (2022).

    • Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome; Clinical and Translational Science; (2021).

    • The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome; Clinical Pharmacology & Therapeutics; (2018).

    • Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.; The New England journal of medicine; (2017).